Viral and bacterial factors of mother-to-child transmission of hepatitis B virus.
HBV
Ivory Coast
bacteria
mother-to-child transmission
viruses
Journal
Journal of viral hepatitis
ISSN: 1365-2893
Titre abrégé: J Viral Hepat
Pays: England
ID NLM: 9435672
Informations de publication
Date de publication:
12 2021
12 2021
Historique:
revised:
30
07
2021
received:
27
05
2021
accepted:
31
07
2021
pubmed:
2
9
2021
medline:
3
2
2022
entrez:
1
9
2021
Statut:
ppublish
Résumé
Hepatitis B virus (HBV) infection is the tenth leading cause of death worldwide. Mother-to-child transmission of HBV occurring mainly at delivery remains one of the most common routes of infection in developing countries. One of the main challenges concerning HBV in Africa is to implement a prevention policy aiming at interrupting the cycle of pseudo-vertical transmission of this infection. The aim of this study was to assess the implication of certain bacterial and viral factors in mother-to-child transmission of HBV. This prospective study was conducted on 165 pregnant women carriers of HBV surface antigen (HBsAg) and their 169 newborns who attended care at the Gynecology Department of the University Hospital of Cocody. Serological, molecular, and bacteriological analyses were performed on blood samples and vaginal secretions. Mean viral load (VL) was 4.5 ± 1.3 log
Substances chimiques
DNA, Viral
0
Hepatitis B Surface Antigens
0
Hepatitis B e Antigens
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1683-1689Informations de copyright
© 2021 John Wiley & Sons Ltd.
Références
WHO, (2020) World hepatitis day. July 28, 2020. https://www.who.int/healthinfo/global_burden_disease/estimates/en/
Feray C. Hepatitis B in Africa: a forgotten epidemic. Humanitarian. 2015;40:68-73.
Sbai A. Epidemiology, genotype and risk factors of viral hepatitis B in Morocco. Ph.D. thesis, Mohammed V-Agdal University, Faculty of Sciences Rabat; 2012:166.
Bagnaka SAFE, Koffi AA, Assi C, et al. Evaluation of the vaccination status against viral hepatitis B of the paramedical staff of the Hospital and University Center of Yopougon in Côte d'Ivoire. J Med Pharm. 2013;3:18.
Servais AF, Eloumou B, Attia KA. Evaluation of immunization status against hepatitis B of paramedical staff in university hospital of Yopougon in Côte-d’Ivoire. J Med Pharm. 2013;3:346-353.
Assi C, Ouattara A, Allah-Kouadio E. Vaccination coverage against the hepatitis B and prevalence of HBsAg: cross-sectional study of 592 persons in Abidjan. Clin Res Hepatol Gastroenterol. 2011;35:506-507.
Vodkin I, Patton H. Management of hepatitis B virus infection during pregnancy. Minerva Gastroenterol Dietol. 2014;60:205-214.
Hyams KC. Risks of chronicity following acute hepatitis B virus infection. Clin Infect Dis. 1995;20:992-1000.
Nelson NP, Jamieson DJ, Murphy TV. Prevention of perinatal hepatitis B virus transmission. J Pediatr Infect Dis Soc. 2014;3:7-12.
Chen DS. Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B. J Hepatol. 2009;50:805-816.
Lohouès-Kouacou MJ, Managbé T, Hillah J, Camara BM. Maternal-fetal transmission of hepatitis B virus in Côte d'Ivoire. Advocacy for mass vaccination. Health Noteb. 1998;8:401-404.
Forbi JC, Ben-Ayed Y, Xia GL. Disparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries. J Clin Virol. 2013;58:59-66.
Suzuki S, Sugauchi F, Orito E. Distribution of hepatitis B virus (HBV) genotypes among HBV carriers in the Côte d’Ivoire: complete genome sequence and phylogenetic relatedness of HBV genotype. J Med Virol. 2003;69:459-465.
Kouassi-M’Bengue A, Ekaza E, Attia A. Distribution of hepatitis B virus genotypes in 50 patients with chronic hepatitis B in Abidjan, Côte-d’Ivoire in 2003. Afr J Biotech. 2007;6:1-12.
Doumbia M, Kouassi-M’Bengue A, Kakou-N’Gazoa S, Sevede D. Molecular characterization of hepatitis B virus isolated from two groups of patients at risk in Côte-d’Ivoire. J Microbiol Res. 2013;1:61-66.
Seri B, Minga A, Gabillard D, et al. Twenty-year evolution of HBV and HIV prevalence and incidence in voluntary blood donors in Côte d’Ivoire. Open Forum Infect Dis. 2018;5(4):ofy060.
Ogunkunle MO, Oni AA, Odaibo GN, Olaleye OD. Hepatitis B surface antigen (HBsAg) in blood and genital secretions of patients with sexually transmitted diseases in Ibadan, Nigeria. West Afr J Med. 2005;24(3):206-208.
Robert-Parra F. Etude descriptive prospective des infections materno-fœtales dans une maternité de niveau III. Evaluations des pratiques et proposition de nouvelles recommandations. Thèse d'exercice en Thèses > Médecine spécialisée, Université Toulouse III - Paul Sabatier. 2014.
Lok ASF. Chronic hepatitis B. N Engl J Med. 2002;346:1682-1683.
Zhang SL, Yue YF, Bai GQ, Shi L, Jiang H. Mechanism of intrauterine infection of hepatitis B virus. World J Gastroenterol. 2004;10(3):437-438.
Sinha S, Kumar M. Pregnancy and chronic hepatitis B virus infection. Hepatol Res. 2010;40(1):31-48.
Navabakhsh B, Mehrabi N, Estakhri A, Mohamadnejad M, Poustchi H. Hepatitis B virus infection during pregnancy: transmission and prevention. Middle East J Dig Dis. 2011;3(2):92-102.
Juganariu G, Andra T, Petrovici C, Nicolau C. Characteristics of hepatitis B virus coinfection among hiv-infected pregnant women. Rev Med Chir. 2015;119:1010-1017.
Pan CQ, Zou HB, Chen Y, et al. Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants. Clin Gastroenterol Hepatol. 2013;10:1349-1355.
Raimondo G, Balsano C, Craxi A, et al. Occult hepatitis B virus infection. Dig Liver Dis. 2000;32:822-826.
Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis. 2000;2:479-486.
Zhang L, Gui XE, Wang B, et al. Serological positive markers of hepatitis B virus in femoral venous blood or umbilical cord blood should not be evidence of in-utero infection among neonates. BMC infect Dis. 2016;16:408.
Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60(367):389.